Role of Membrane Lipids in the Regulation of Erythrocytic Oxygen-Transport Function in Cardiovascular Diseases

Table 3

Changes of oxygen binding ability of hemoglobin in the course of treatment of IHD patients and healthy persons (means ± SD).

Patients groups	Variants
	Relative quantity of o-Hb in blood, rel. Un.; /( + )	Relative ability of Hb to bind ligands (including O2), rel. Un.; /	Relative ability of Hb to isolate ligands, rel. Un.; /	Affinity of Hb to ligands, first of all to O2, rel. Un.; (/)/(/)
Donors	0.76 ± 0.02	0.65 ± 0.03	0.58 ± 0.02	1.28 ± 0.02
⁢Patients before treatment
SA patients before treatment	0.54 ± 0.03	0.87 ± 0.03	0.31 ± 0.02	1.86 ± 0.04
SA+HT patients before treatment	0.45 ± 0.03	1.02 ± 0.03	0.36 ± 0.02	1.77 ± 0.04
⁢Patients after treatment
SA patients after treatment	0.63 ± 0.03	0.73 ± 0.03	0.45 ± 0.03	1.26 ± 0.02
SA+HT patients after treatment	0.49 ± 0.08	0.75 ± 0.07	0.39+0.04	1.47 ± 0.04

Reliability in relation to donors’ indicators.
Reliability in relation to pretreatment indicators at .